Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Qlaira (EV/DNG) for Contraception
NCT01638910Phase 3Completed
- Sponsor
- Bayer
- Start
- Jun 2012
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of estradiol valerate + dienogest in contraception, sponsored by Bayer. Started Jun 2012; status: completed.
02
Drugs
estradiol valerate + dienogest
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01638910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638910.